Relapsed or refractory B-cell Non-Hodgkin lymphoma

4 total trials 3 recruiting

Filter these 4 trials by phase, country, sponsor and more.

Open in Search →

A Phase 1/2a Study of UCART20x22 in B-Cell Non-Hodgkin Lymphoma [NatHaLi-01] Recruiting

2022-501607-27-00 7 2026-01-06
A Phase 1b Open-Label Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination with Other Anti-cancer … Recruiting

2024-512089-32-00 3 2022-03-28
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Subcutaneous Glofitamab following Obinutuz … Recruiting

2023-507728-22-00 3 2021-06-25
A phase 2 trial to study safety and efficacy of Capivasertib in patients with blood cancer where disease or cancer cell grows after a period … Ended

2024-516386-36-00 4 2022-03-04

Showing 1–4 of 4 trials